October 23, 2026
Laura Minquini is not a scientist, but that hasn’t stopped her from joining the front lines of the war on aging: specifically, female reproductive aging. Several years ago, after a successful stint in consumer technology, Laura discovered the longevity field when decentralized science was all the rage. Inspired by VitaDAO’s success, she founded AthenaDAO, a...
November 12, 2025
The idea of living longer, healthier lives thanks to rejuvenation biotechnology has steadily become more common. Gradually increasing numbers of articles are discussing this idea, especially as science is starting to catch up and may eventually even deliver on it. With that in mind, I was pleasantly surprised this week to be greeted by an...
October 10, 2023
If you want to contribute to Lifespan.io and use cryptocurrency, there is a great opportunity happening right now to support our work! Donate to help us solve aging We promote the advancement of medical technologies that will increase healthy human longevity. By sponsoring, democratizing, and funding aging research, combined with responsible journalism, we aim...
April 28, 2023
We have two scientific research projects in the new Gitcoin fundraising round. Help us to combat Alzheimer's disease or improve how clinical trials are conducted today! An alternative way to fund science Gitcoin is a decentralized science (DeSci) platform that utilizes blockchain technology to support the development of open-source projects using Web3 technologies, with the...
January 31, 2023
VitaDAO, a decentralized organization funding early-stage longevity research and biotech start-ups, has announced the successful closing of a $4.1 million funding round dedicated to financing future longevity projects and furthering its commercialization and licensing strategy for IP-NFT assets. Key contributors to the fundraising round include Shine Capital, L1 Digital, decentralized science and Web3 organizations Beaker...
May 17, 2022
We have written extensively about VitaDAO, a collective dedicated to community-governed, decentralized drug development. Probably the fastest and cheapest way to get geroprotective drugs to the market is by repurposing existing drugs, such as rapamycin, metformin, and acarbose. These drugs cost next to nothing, have a known safety record, and have shown a lot of...